Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems
Jingjun Yan(Tongji Hospital), Xingxing He(Wuhan University), Ju‐Sheng Lin(Tongji Hospital), Jiazhi Liao(Tongji University)
Cited by 33
Related Papers
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
|Journal of Experimental & Clinical Cancer Research|2021|216
The role of autophagy in hepatocellular carcinoma: friend or foe
|Oncotarget|2017|152
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
|Experimental Hematology and Oncology|2021|101
MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1
|Oncotarget|2015|100
PI3 kinase/Akt signaling mediates epithelial–mesenchymal transition in hypoxic hepatocellular carcinoma cells
|Biochemical and Biophysical Research Communications|2009|100